Comments

Camp4 Therapeutics Stock Guidance

CAMPNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
Camp4 Therapeutics (CAMP) ForecastNewsEarningsCamp4 Therapeutics (CAMP) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Camp4 Therapeutics Stock Guidance | NASDAQ:CAMP | Benzinga

Camp4 Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
07/10/2023CAMP
CalAmp
Q22024———$67.00M$73.00M$77.14MGet Alert
04/27/2023CAMP
CalAmp
Q12024———$72.00M$78.00M$76.49MGet Alert

FAQ

Q

What is the most recent guidance for Camp4 Therapeutics (CAMP)?

A

There have been no specific sales or earnings guidance reported for Camp4 Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved